Influenza and pneumococcal vaccination in hospitalized adults with pandemic (H1N1) 2009: Immunization practices and impact on clinical presentation and outcomes
Journal Title: Journal of Vaccines & Immunization - Year 2013, Vol 1, Issue 3
Abstract
The purpose of this study was to determine vaccination rates against influenza and pneumococcus in a large cohort of adults hospitalized with confirmed influenza A(H1N1) pdm09 infection, and to identify differences in clinical features, frequency of bacterial coinfection, and outcomes between vaccinated and non-vaccinated patients. A prospective cohort study conducted at 14 teaching hospitals in Spain. Adult patients (n=699) hospitalized with confirmed influenza A(H1N1)pdm09 infection during the pandemic and the first post pandemic influenza periods were included. Vaccination status against influenza and pneumococcus was established in 547 and 587 individuals, respectively. The vaccination rates were low: 14% for seasonal influenza and 5.4% for pneumococcus. Despite conducting whole population and subgroup multivariate analyses, we observed no beneficial effects on outcomes (intensive care unit admission and mortality) for both vaccines. However, patients who had been vaccinated, whether against influenza or pneumococcus, did tend to develop fewer bacterial coinfections, particularly that due to S. pneumoniae.
Authors and Affiliations
Payeras A, Riera M, Viasus D, Gálvez-Acebal J, Oteo JA, Gracia-Ahufinger I, Caro-Bragado S, Cordero E, Martínez-Montauti J, Fariñas MC, Carratalà J
Keywords
Related Articles
- EP ID EP567026
- DOI 10.14312/2053-1273.2013-4
- Views 68
- Downloads 0
Immunogenicity of 13-valent pneumococcal conjugate vaccine in immunocompetent older adults with stable underlying medical conditions
The 13-valent pneumococcal conjugate vaccine (PCV13) elicits robust functional antibody responses in immunocompetent adults aged ≥50 years, including healthy adults and those considered at risk (ie, stable, chronic cardi...
An evaluation of the indirect cohort method to estimate the effectiveness of the pneumococcal polysaccharide vaccine
We examined the validity of the indirect cohort method as a rapid assessment tool to estimate pneumococcal polysaccharide vaccine effectiveness (VE). Using evidence from published clinical trials, we reviewed the primary...
Comparison of the live attenuated mumps vaccine (Miyahara strain) with its preattenuated parental strain
Live attenuated mumps vaccines have been developed by passaging the field isolates in cells that differ from the natural host. To study mumps viral (MuV) attenuation at the genomic level, we compared a live attenuated mu...
Silk-based microneedle transdermal immunization with EV71 vaccines elicits potent immune responses in mice
Hand, foot, and mouth disease (HFMD), caused by EV71 viral infection, has emerged as a serious public health concern in the Asia-Pacific region. The lack of effective treatment has led to a focus on controlling EV71 epid...
Events following BCG vaccination during neonatal period and factors that might affect potency and side effects
Introduction: In Sri Lanka, BCG vaccine is given during neonatal period. There are many myths regarding BCG vaccine and sequelae of vaccination are not clearly documented in medical literature. Objectives: Objectives of...